Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.2827
-0.0072 (-2.48%)
At close: Sep 4, 2025, 4:00 PM
0.2913
+0.0086 (3.04%)
After-hours: Sep 4, 2025, 7:11 PM EDT
Leap Therapeutics Market Cap
Leap Therapeutics has a market cap or net worth of $11.71 million as of September 4, 2025. Its market cap has decreased by -87.71% in one year.
Market Cap
11.71M
Enterprise Value
-6.48M
1-Year Change
-87.71%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since January 25, 2017, Leap Therapeutics's market cap has decreased from $73.80M to $11.71M, a decrease of -84.13%. That is a compound annual growth rate of -19.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 12.00M | -89.11% |
| Dec 31, 2024 | 110.20M | 3.96% |
| Dec 29, 2023 | 106.00M | 137.67% |
| Dec 30, 2022 | 44.60M | -84.42% |
| Dec 31, 2021 | 286.20M | 113.26% |
| Dec 31, 2020 | 134.20M | 395.20% |
| Dec 31, 2019 | 27.10M | -7.82% |
| Dec 31, 2018 | 29.40M | -49.83% |
| Dec 29, 2017 | 58.60M | -20.60% |
| Jan 25, 2017 | 73.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.81B |
| Johnson & Johnson | 428.59B |
| AbbVie | 375.15B |
| UnitedHealth Group | 280.59B |
| AstraZeneca | 254.65B |
| Novo Nordisk | 249.80B |
| Novartis AG | 248.54B |
| Abbott Laboratories | 231.53B |